Pharma Industry News

Illumina names new commercial, legal chiefs as sequencing business shows signs of stability

Illumina has filled two key C-suite posts, naming Mike Sullivan as chief commercial officer and Julie Coletti as chief legal officer as the DNA sequencing giant works to keep its turnaround on track after years of regulatory, geopolitical and investor turbulence.

Source: FierceBiotech

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]